Viewing StudyNCT00034476



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034476
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2002-04-29

Brief Title: A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Conditions & Keywords Data

Conditions:
Name
Sepsis
Keywords:
Name View
Sepsis sPLA2 Inhibitor View